Carl Zeiss AG, the holding company of the ZEISS Group, announced yesterday that it will buy additional Carl Zeiss Meditec shares on the stock market for up to €200 million by February 2027, mainly to underline confidence in the subsidiary and its strategy. The group currently holds about 59.1 percent ...

Buying a membership today will give you:
To continue reading this article register now.